Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort

被引:11
作者
Batsuli, Glaivy [1 ,2 ]
Wheeler, Allison P. [3 ]
Weyand, Angela C. [4 ]
Sidonio, Robert F. [1 ,2 ]
Young, Guy [5 ,6 ]
机构
[1] Emory Univ, Dept Pediat, Atlanta, GA USA
[2] Childrens Healthcare Atlanta, Atlanta, GA USA
[3] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN USA
[4] Univ Michigan, Dept Pediat, Med Sch, Ann Arbor, MI USA
[5] Univ Southern Calif, Childrens Hosp Los Angeles, Canc & Blood Disorders Inst, Keck Sch Med, Los Angeles, CA USA
[6] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, 4650 Sunset Blvd, Mail Stop 54, Los Angeles, CA 90027 USA
关键词
D O I
10.1002/ajh.27039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E285 / E287
页数:3
相关论文
共 6 条
[1]   Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies [J].
Callaghan, Michael U. ;
Negrier, Claude ;
Paz-Priel, Ido ;
Chang, Tiffany ;
Chebon, Sammy ;
Lehle, Michaela ;
Mahlangu, Johnny ;
Young, Guy ;
Kruse-Jarres, Rebecca ;
Mancuso, Maria Elisa ;
Niggli, Markus ;
Howard, Monet ;
Bienz, Nives Selak ;
Shima, Midori ;
Jimenez-Yuste, Victor ;
Schmitt, Christophe ;
Asikanius, Elina ;
Levy, Gallia G. ;
Pipe, Steven W. ;
Oldenburg, Johannes .
BLOOD, 2021, 137 (16) :2231-2242
[2]   A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model [J].
Kitazawa, Takehisa ;
Igawa, Tomoyuki ;
Sampei, Zenjiro ;
Muto, Atsushi ;
Kojima, Tetsuo ;
Soeda, Tetsuhiro ;
Yoshihashi, Kazutaka ;
Okuyama-Nishida, Yukiko ;
Saito, Hiroyuki ;
Tsunoda, Hiroyuki ;
Suzuki, Tsukasa ;
Adachi, Hideki ;
Miyazaki, Taro ;
Ishii, Shinya ;
Kamata-Sakurai, Mika ;
Iida, Takeo ;
Harada, Aya ;
Esaki, Keiko ;
Funaki, Miho ;
Moriyama, Chifumi ;
Tanaka, Eriko ;
Kikuchi, Yasufumi ;
Wakabayashi, Tetsuya ;
Wada, Manabu ;
Goto, Masaaki ;
Toyoda, Takeshi ;
Ueyama, Atsunori ;
Suzuki, Sachiyo ;
Haraya, Kenta ;
Tachibana, Tatsuhiko ;
Kawabe, Yoshiki ;
Shima, Midori ;
Yoshioka, Akira ;
Hattori, Kunihiro .
NATURE MEDICINE, 2012, 18 (10) :1570-U177
[3]   Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors [J].
Mahlangu, J. ;
Oldenburg, J. ;
Paz-Priel, I. ;
Negrier, C. ;
Niggli, M. ;
Mancuso, M. E. ;
Schmitt, C. ;
Jimenez-Yuste, V. ;
Kempton, C. ;
Dhalluin, C. ;
Callaghan, M. U. ;
Bujan, W. ;
Shima, M. ;
Adamkewicz, J. I. ;
Asikanius, E. ;
Levy, G. G. ;
Kruse-Jarres, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (09) :811-822
[4]   Emicizumab Prophylaxis in Hemophilia A with Inhibitors [J].
Oldenburg, Johannes ;
Mahlangu, Johnny N. ;
Kim, Benjamin ;
Schmitt, Christophe ;
Callaghan, Michael U. ;
Young, Guy ;
Santagostino, Elena ;
Kruse-Jarres, Rebecca ;
Negrier, Claude ;
Kessler, Craig ;
Valente, Nancy ;
Asikanius, Elina ;
Levy, Gallia G. ;
Windyga, Jerzy ;
Shima, Midori .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :809-818
[5]   Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study [J].
Pipe, Steven W. ;
Shima, Midori ;
Lehle, Michaela ;
Shapiro, Amy ;
Chebon, Sammy ;
Fukutake, Katsuyuki ;
Key, Nigel S. ;
Portron, Agnes ;
Schmitt, Christophe ;
Podolak-Dawidziak, Maria ;
Bienz, Nives Selak ;
Hermans, Cedric ;
Campinha-Bacote, Avrita ;
Kiialainen, Anna ;
Peerlinck, Kathelijne ;
Levy, Gallia G. ;
Jimenez-Yuste, Victor .
LANCET HAEMATOLOGY, 2019, 6 (06) :E295-E305
[6]   A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors [J].
Young, Guy ;
Liesner, Ri ;
Chang, Tiffany ;
Sidonio, Robert, Jr. ;
Oldenburg, Johannes ;
Jimenez-Yuste, Victor ;
Mahlangu, Johnny ;
Kruse-Jarres, Rebecca ;
Wang, Michael ;
Uguen, Marianne ;
Doral, Michelle Y. ;
Wright, Lilyan Y. ;
Schmitt, Christophe ;
Levy, Gallia G. ;
Shima, Midori ;
Mancuso, Maria Elisa .
BLOOD, 2019, 134 (24) :2127-2138